Table 3.

Univariate analysis of the presence of potentially inappropriate medication and pharmacotherapeutic variables

Pharmacotherapeutic characteristics	STOPP Compliant n (%) vs. non-compliant n (%) p-value	Marc Compliant n (%) vs. non-compliant n (%) p-value	PRISCUS Compliant n (%) vs. non-compliant n (%) p-value
Polypharmacy (n=39)	14 (82.4%) vs 25 (65.8%) p=0.067	28 (77.8%) vs 11 (57.9%) p=0.067	7 (87.5%) vs 32 (68.1%) p=0.414
Major polypharmacy (n=14)	8 (47.1%) vs 6 (15.8%) p=0.021	14 (38.9%) vs 0 (0%) p=0.001	3 (37.5%) vs 11 (23.4%) p=0.405
Polypharmacy pattern (n=26)	11 (64.7%) vs 15 (39.5%) p=0.003	24 (66.7%) vs 2 (10.5%) p=0.003	5 (62.5%) vs 21 (44.7%) p=0.510
Multimorbidity pattern (n=35)	13 (76.5%) vs 22 (57.9%) p=0.335	29 (80.6%) vs 6 (31.6%) p=0.003	7 (87.5%) vs 28 (59.6%) p=0.064